Tome Biosciences
Biotech · Private
Programmable genomic integration platform (PING) for inserting large DNA sequences into precise chromosomal locations
tomebio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 29
- 0 granted · 29 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2050 | SAMDI TECH, INC. | — | — |
| 2051 | CORD BLOOD PLUS, INC. | — | — |
| 2052 | ViraCyte LLC | — | — |
| 2053 | Tome Biosciences | — | — |
| 2054 | Advanced Solutions Holdings, Inc. | — | $36M |
| 2055 | CATENA BIOSCIENCES, INC. | — | — |
| 2056 | Aspen Stem Cell Institute, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Systems, Compositions, And Methods For Targeting Liver Sinusodial Endothelial Cells (lsecs)application
- Revision Of Genetic Material Using Direct Replacement Editingapplication
- Revision Of Genetic Material Using Direct Replacement Editingapplication
- Revision Of Genetic Material Using Direct Replacement Editingapplication
- Platforms, Compositions, And Methods For In Vivo Programmable Gene Insertionapplication
- Systems And Methods For In Vivo Programmable Gene Insertionapplication
- Programmable Gene Insertion Using Engineered Integration Enzymesapplication
- Pleiopluripotent Stem Cell Programmable Gene Insertionapplication
- Ex Vivo Programmable Gene Insertionapplication
- Systems, Compositions, And Methods For Targeting Liver Sinusodial Endothelial Cells (lsecs)application
- Guide Rna Compositions For Programmable Gene Insertionapplication
- Programmable Gene Insertion Compositionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.